SILK - Silk Road Medical, Inc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.25B
Enterprise Value 31.18B
Trailing P/E N/A
Forward P/E 1-54.04
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)25.56
Price/Book (mrq)14.77
Enterprise Value/Revenue 324.15
Enterprise Value/EBITDA 6-48.26

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 3-0.33%
52 Week High 351.50
52 Week Low 330.87
50-Day Moving Average 341.49
200-Day Moving Average 342.15

Share Statistics

Avg Vol (3 month) 3278.15k
Avg Vol (10 day) 3628.16k
Shares Outstanding 530.67M
Float 18.13M
% Held by Insiders 11.77%
% Held by Institutions 167.87%
Shares Short (Jul 31, 2019) 4895.49k
Short Ratio (Jul 31, 2019) 44.47
Short % of Float (Jul 31, 2019) 49.73%
Short % of Shares Outstanding (Jul 31, 2019) 42.92%
Shares Short (prior month Jun 28, 2019) 4331.1k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -124.42%
Operating Margin (ttm)-51.55%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)48.78M
Revenue Per Share (ttm)5.07
Quarterly Revenue Growth (yoy)92.20%
Gross Profit (ttm)23.68M
EBITDA -24.41M
Net Income Avi to Common (ttm)-60.69M
Diluted EPS (ttm)-6.30
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)118.25M
Total Cash Per Share (mrq)3.84
Total Debt (mrq)49.52M
Total Debt/Equity (mrq)58.69
Current Ratio (mrq)14.32
Book Value Per Share (mrq)2.74

Cash Flow Statement

Operating Cash Flow (ttm)-29.76M
Levered Free Cash Flow (ttm)N/A